• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis.

出版信息

CADTH Technol Overv. 2010;1(1):e0106. Epub 2010 Mar 1.

PMID:22977394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3411137/
Abstract
摘要

相似文献

1
Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis.与新鲜冰冻血浆相比，Octaplas可降低传播脂包膜病毒的风险：一项经济分析和预算影响分析。
CADTH Technol Overv. 2010;1(1):e0106. Epub 2010 Mar 1.
2
Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.单一中心在急性血栓性血小板减少性紫癜中使用冷上清液和溶剂去污剂新鲜冰冻血浆（Octaplas）的情况。
Vox Sang. 2007 Aug;93(2):154-8. doi: 10.1111/j.1423-0410.2007.00940.x.
3
Stability of solvent/detergent-treated plasma and single-donor fresh-frozen plasma during 48 h after thawing.解冻后48小时内溶剂/去污剂处理血浆和单供体新鲜冰冻血浆的稳定性
Transfus Apher Sci. 2005 Nov;33(3):257-67. doi: 10.1016/j.transci.2005.07.005. Epub 2005 Oct 3.
4
Efficacy of solvent/detergent plasma after storage at 2-8 °C for 5 days in comparison to other plasma products to improve factor V levels in factor V deficient plasma.与其他血浆制品相比，溶剂/去污剂处理的血浆在2-8°C储存5天后提高V因子缺乏血浆中V因子水平的效果。
Transfus Apher Sci. 2016 Aug;55(1):114-9. doi: 10.1016/j.transci.2016.04.015. Epub 2016 Apr 26.
5
A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment.对一种获得药品许可的凝血活性血浆（Octaplas）、一种通用的研发产品（Uniplas）以及经过亚甲蓝染色和白光处理的单供体新鲜冰冻血浆进行生化比较。
Transfus Apher Sci. 2006 Dec;35(3):223-33. doi: 10.1016/j.transci.2006.08.008. Epub 2006 Nov 21.
6
7
Viral safety of solvent/detergent-treated plasma.
Transfusion. 2000 Jan;40(1):84-90. doi: 10.1046/j.1537-2995.2000.40010084.x.
8
Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma.溶剂/去污剂处理血浆与新鲜冰冻血浆的凝血因子含量比较。
Blood Coagul Fibrinolysis. 2003 Apr;14(3):283-7. doi: 10.1097/01.mbc.0000061298.28953.7d.
9
Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS.人血浆的溶剂/去污剂处理——一种非常可靠的病毒灭活方法。OCTAPLAS经验证的病毒安全性。
Vox Sang. 1998;74 Suppl 1:207-12. doi: 10.1111/j.1423-0410.1998.tb05474.x.
10
Virally inactivated fresh frozen plasma.病毒灭活新鲜冰冻血浆
Vox Sang. 1995;69(3):159-65. doi: 10.1111/j.1423-0410.1995.tb02590.x.

引用本文的文献

1
Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan.台湾骨质疏松症药物用于骨折初级预防的预算影响分析。
J Bone Miner Metab. 2020 May;38(3):316-327. doi: 10.1007/s00774-019-01061-5. Epub 2019 Nov 11.
2
Xenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply.嗜异性小鼠白血病病毒相关病毒（XMRV）与血液供应安全
Clin Microbiol Rev. 2016 Oct;29(4):749-57. doi: 10.1128/CMR.00086-15.

本文引用的文献

1
Modern plasma fractionation.现代血浆分级分离法。
Transfus Med Rev. 2007 Apr;21(2):101-17. doi: 10.1016/j.tmrv.2006.11.001.
2
Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma.溶剂/去污剂处理的新鲜冰冻血浆的成本效益
Vox Sang. 2003 Aug;85(2):88-95. doi: 10.1046/j.1423-0410.2003.00329.x.
3
Pathogen inactivation of labile blood products.不稳定血液制品的病原体灭活
Transfus Med. 2001 Jun;11(3):149-75. doi: 10.1046/j.1365-3148.2001.00310.x.
4
Responsible use of blood products in response to supply and demand.
Am J Health Syst Pharm. 2000 Nov 15;57(22):2094-8. doi: 10.1093/ajhp/57.22.2094.
5
Reducing the risk of infection from plasma products: specific preventative strategies.降低血浆制品感染风险：特定预防策略
Blood Rev. 2000 Jun;14(2):94-110. doi: 10.1054/blre.2000.0129.
6
Cost-effectiveness of transfusing virus-inactivated plasma instead of standard plasma.
Transfusion. 1999 May;39(5):479-87. doi: 10.1046/j.1537-2995.1999.39050479.x.
7
Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply.
JAMA. 1994 Oct 19;272(15):1210-4.